Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2007 (2007), Article ID 93857, 6 pages
http://dx.doi.org/10.1155/2007/93857
Research Article

Secretory Leukocyte Protease Inhibitor Is an Inducible Antimicrobial Peptide Expressed in Staphylococcus aureus Endophthalmitis

1Cornea and External Eye Diseases Lab, School of Medicine, Catholic University of Cordoba, Cordoba 5021, Argentina
2Department of Biochemistry and Molecular Biology, School of Medicine, National University of Cordoba, Cordoba 5022, Argentina
3Cornea and External Diseases, Bascom Palmer, School of Medicine, University of Miami, Miami, FL 33136, USA
4Cornea Department, The Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD 21287, USA

Received 19 June 2007; Accepted 30 October 2007

Copyright © 2007 Victor E. Reviglio et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Results of the Endophthalmitis Vitrectomy Study, “A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group,” Archives of Ophthalmology, vol. 113, no. 12, pp. 1479–1496, 1995. View at Google Scholar
  2. N. R. Powe, O. D. Schein, S. C. Gieser et al., “Synthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation. Cataract Patient Outcome Research Team,” Archives of Ophthalmology, vol. 112, no. 2, pp. 239–252, 1994, Erratum in Archives of Ophthalmology, vol. 112, no. 7, p. 889, 1994. View at Google Scholar
  3. D. P. Han, S. R. Wisniewski, L. A. Wilson et al., “Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study,” American Journal of Ophthalmology, vol. 122, no. 1, pp. 1–17, 1996, Erratum in American Journal of Ophthalmology, vol. 122, no. 6 p. 920, 1996. View at Google Scholar
  4. R. E. Engstrom, B. J. Mondino, B. J. Glasgow, H. P. Halabi, and S. A. Adamu, “Immune response to Staphylococcus aureus endophthalmitis in a rabbit model,” Investigative Ophthalmology & Visual Science, vol. 32, no. 5, pp. 1523–1533, 1991. View at Google Scholar
  5. M. Zasloff, “Antibiotic peptides as mediators of innate immunity,” Current Opinion in Immunology, vol. 4, no. 1, pp. 3–7, 1992. View at Publisher · View at Google Scholar
  6. E. Martin, T. Ganz, and R. I. Lehrer, “Defensins and other endogenous peptide antibiotics of vertebrates,” Journal of Leukocyte Biology, vol. 58, no. 2, pp. 128–136, 1995. View at Google Scholar
  7. R. I. Lehrer, A. K. Lichtenstein, and T. Ganz, “Defensins: antimicrobial and cytotoxic peptides of mammalian cells,” Annual Review of Immunology, vol. 11, pp. 105–128, 1993. View at Publisher · View at Google Scholar · View at PubMed
  8. X.-Y. Song, L. Zeng, W. Jin et al., “Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis,” The Journal of Experimental Medicine, vol. 190, no. 4, pp. 535–542, 1999. View at Publisher · View at Google Scholar
  9. J. F. C. Tomee, G. H. Koëter, P. S. Hiemstra, and H. F. Kauffman, “Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option?,” Thorax, vol. 53, no. 2, pp. 114–116, 1998. View at Google Scholar
  10. P. S. Hiemstra, R. J. Maassen, J. Stolk, R. Heinzel-Wieland, G. J. Steffens, and J. H. Dijkman, “Antimicrobial activity of antileukoprotease,” Infection and Immunity, vol. 64, no. 11, pp. 4520–4524, 1996. View at Google Scholar
  11. F. Y. Jin, C. Nathan, D. Radzioch, and A. Ding, “Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide,” Cell, vol. 88, no. 3, pp. 417–426, 1997. View at Publisher · View at Google Scholar
  12. F. Y. Jin, C. Nathan, D. Radzioch, and A. Ding, “Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide,” Cell, vol. 88, no. 3, pp. 417–426, 1997. View at Publisher · View at Google Scholar
  13. J. M. Sallenave, J. Shulmann, J. Crossley, M. Jordana, and J. Gauldie, “Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes,” American Journal of Respiratory Cell and Molecular Biology, vol. 11, no. 6, pp. 733–741, 1994. View at Google Scholar
  14. J. F. C. Tomee, P. S. Hiemstra, R. Heinzel-Wieland, and H. F. Kauffman, “Antileukoprotease: and endogenous protein in the innate mucosal defense against fungi,” Journal of Infectious Diseases, vol. 176, no. 3, pp. 740–747, 1997. View at Google Scholar
  15. D. P. Maxwel, B. D. Brent, R. Orillac, W. B. Baber, and P. A. Mayeux, “A natural history study of experimental Staphylococcus epidermidis endophthalmitis,” Current Eye Research, vol. 12, no. 10, pp. 907–912, 1993. View at Google Scholar
  16. Y. St-Pierre and E. F. Potworowski, “T cell control of extracellular matrix degradation,” Developmental Immunology, vol. 7, no. 2–4, pp. 171–177, 2000. View at Google Scholar
  17. G. G. Vaday and O. Lider, “Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation,” Journal of Leukocyte Biology, vol. 67, no. 2, pp. 149–159, 2000. View at Google Scholar
  18. E. J. Goetzl, M. J. Banda, and D. Leppert, “Matrix metalloproteinases in immunity,” Journal of Immunology, vol. 156, no. 1, pp. 1–4, 1996. View at Google Scholar
  19. A. Zlotnik, J. Morales, and J. A. Hendrick, “Recent advances in chemokines and chemokine receptors,” Critical Reviews in Immunology, vol. 19, no. 1, pp. 1–47, 1999. View at Google Scholar
  20. R. Bals, X. Wang, R. L. Meegalla et al., “Mouse B-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs,” Infection and Immunity, vol. 67, pp. 3542–3547, 1999. View at Google Scholar
  21. K. Ohlsson, M. Rosengren, G. Stetler et al., “Structure, genomic organization and tissue distribution of human secretory leukocyte-protease inhibitor (SLPI): a potent inhibitor of neutrophil elastase,” in Pulmonary Emphysema and Proteolysis, J. C. Taylor and C. Mittman, Eds., pp. 307–322, Academic Press II, Orlando, Fla, USA, 1986. View at Google Scholar
  22. A. S. Jacoby, J. Melrose, B. G. Robinson, V. J. Hyland, and P. Ghosh, “Secretory leukocyte proteinase inhibitor is produced by human articular cartilage chondrocytes and intervertebral disc fibrochondrocytes,” European Journal of Biochemistry, vol. 218, no. 3, pp. 951–957, 1993. View at Publisher · View at Google Scholar
  23. Q. Zhang, K. Shimoya, A. Moriyama et al., “Production of secretory leukocyte protease inhibitor by human amniotic membranes and regulation of its concentration in amniotic fluid,” Molecular Human Reproduction, vol. 7, no. 6, pp. 573–579, 2001. View at Publisher · View at Google Scholar
  24. P. S. Hiemstra, R. J. Maassen, J. Stolk et al., “Antibacterial activity of antileukoprotease,” Infection and Immunity, vol. 64, no. 11, pp. 4520–4524, 1996. View at Google Scholar
  25. A. Moriyama, K. Shimoya, I. Ogata et al., “Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle,” Molecular Human Reproduction, vol. 5, no. 7, pp. 656–661, 1999. View at Publisher · View at Google Scholar
  26. S. Sathe, M. Sakata, A. R. Beaton, and R. A. Sack, “Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid,” Current Eye Research, vol. 17, no. 4, pp. 348–362, 1998. View at Publisher · View at Google Scholar